AI Assistant
Blog
Pricing
Log In
Sign Up
Mutations in Wilms tumor 1 (WT1) as a biomarker for patient outcome in pediatric acute myelogenous leukemia (AML)
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
